ABSAX
Price
$26.46
Change
+$0.07 (+0.27%)
Updated
Jul 31 closing price
Net Assets
3.74B
DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
Interact to see
Advertisement

ABSAX vs DFSVX

ABSAX vs DFSVX Comparison Chart in %
View a ticker or compare two or three
VS
ABSAX vs. DFSVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSAX is a StrongBuy and DFSVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. ABSAX (3.74B). DFSVX pays higher dividends than ABSAX: DFSVX (1.50) vs ABSAX (0.70). ABSAX was incepted earlier than DFSVX: ABSAX (16 years) vs DFSVX (33 years). ABSAX (1.24) is less costly to investors than DFSVX (0.31). ABSAX is a more actively managed with annual turnover of: 75.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than ABSAX: DFSVX (0) vs ABSAX (2500). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. ABSAX (23.49). DFSVX return over 5 years is better than : 50.66 vs. ABSAX (-1.18).
ABSAXDFSVXABSAX / DFSVX
Total Expense Ratio1.240.31400%
Annual Report Gross Expense Ratio1.240.31400%
Fund Existence16 years33 years-
Gain YTD26.18021.336123%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.74B19.5B19%
Annual Yield % from dividends0.701.5047%
Returns for 1 year23.4934.3968%
Returns for 3 years17.4850.3735%
Returns for 5 years-1.1850.66-2%
Returns for 10 years23.49107.7122%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I